Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Given Average Recommendation of “Moderate Buy” by Analysts
Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) has received an average recommendation of “Moderate Buy” from the five research firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price […]
Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) has received an average recommendation of “Moderate Buy” from the five research firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price […]
